Curanex Pharmaceuticals Inc
CURXHealthcare·Biotechnology·USA·Nano·NASD·Nov 12 • 3:59 PM ET
5.67+0.01 (0.18%)
2026-11-13 05:03 CET
Market cap
$8.90M
Revenue, TTM
0.00 USD m
Net income, TTM
-10.47 USD m
Free cash flow, TTM
-12.08 USD m
EPS diluted, TTM
-7.38
Price
CURX against its 20, 50 and 200-day averagesPatternshover a marker to name it
57.5% under the 52-week high of 13.33 on 26 Feb 2026. 52-week low 3.58 on 27 Jul 2026. Last 15 sessions, 44.2% high to low
Volume 0.06× normal · the line is the 50-bar volume average
Setup. RS line 1
CANSLIM 0 of 6 — fails: EPS Growth Qtr Over Qtr: High (>25%); 52-Week High/Low: 0-10% below High; Performance: Year +50%; Institutional Ownership: Over 50%; Average Volume: Over 200K — not on the tape: EPS Growth This Year: High (>25%)
VCP 3 of 6 — fails: 200-Day Simple Moving Average: Price above SMA200; 50-Day Simple Moving Average: SMA50 above SMA200; 52-Week High/Low: 0-10% below High
Minervini 0 of 4 — fails: 200-Day Simple Moving Average: Price above SMA200; 50-Day Simple Moving Average: SMA50 above SMA200; 52-Week High/Low: 0-10% below High; Performance: Year +50%
Zanger 1 of 5 — fails: Performance: Week +10%; 20-Day High/Low: 0-5% below High; Relative Volume: Over 1.5; 200-Day Simple Moving Average: Price above SMA200
Leaders 1 of 5 — fails: 200-Day Simple Moving Average: Price above SMA200; Performance: Year +50%; Average Volume: Over 500K; 52-Week High/Low: 0-10% below High
Breakout 1 of 4 — fails: 52-Week High/Low: New High; Relative Volume: Over 2; 200-Day Simple Moving Average: Price above SMA200
Growth 0 of 4 — fails: EPS Growth Qtr Over Qtr: High (>25%); Return on Equity: Over +15% — not on the tape: EPS Growth This Year: High (>25%); EPS Growth Next Year: High (>25%)
Quality 2 of 5 — fails: Return on Equity: Over +15% — not on the tape: Net Profit Margin: High (>20%); P/E: Under 25
Value 2 of 4 — fails: Return on Equity: Over +15% — not on the tape: P/E: Under 15
Income 0 of 4 — fails: Dividend Growth: Growing 2+ Years — not on the tape: Dividend Yield: Over 2%; Payout Ratio: Low (<20%); P/E: Under 25
Small Cap 1 of 4 — fails: Average Volume: Over 500K; 200-Day Simple Moving Average: Price above SMA200; Performance: Year +50%
Accumulation 0 of 4 — fails: Institutional Ownership: Over 30%; Institutional Transactions: Over +10%; 200-Day Simple Moving Average: Price above SMA200; Performance: Year Up
Relative Strength 0 of 3 — fails: Performance: Year +100%; 200-Day Simple Moving Average: Price above SMA200; Average Volume: Over 500K
Profile
CURX52-week range, 21% of the way up
3.5813.33
Curanex Pharmaceuticals, Inc. engages in the pharmaceutical business. It focuses on developing and commercializing botanical treatments for inflammatory diseases. The company was founded by Ying Jing and Chang Liu in 1996 and is headquartered in Jericho, NY.
| Employees | 6 |
|---|---|
| IPO | Aug 26, 2025 |
| Beta | -3.04 |
| ATR, 14d | 0.45 |
| Rel volume | 0.06 |
| Short float | 0.97% |
| Insider own | 61.35% |
| Inst own | 0.87% |
Snapshot
6 groupsValuation
| Index | - |
|---|---|
| Market Cap | $8.90M |
| Enterprise Value | 6.24M |
| Income | -10.47M |
| Sales | 0.00M |
| Book / share | 3.38 |
| Cash / share | 1.87 |
| Dividend Est. | - |
| Dividend TTM | - |
| Dividend Ex-Date | - |
| Dividend Gr. 3/5Y | - - |
| Payout | - |
| Employees | 6 |
| IPO | Aug 26, 2025 |
Ratios
| Price / earnings | - |
|---|---|
| Forward price / earnings | - |
| Price / earnings / growth | - |
| Price / sales | - |
| Price / book | 1.68 |
| Price / cash | 3.03 |
| Price / free cash flow | - |
| Value / cash profit | - |
| Value / sales | - |
| Quick Ratio | 45.95 |
| Current Ratio | 45.95 |
| Debt / equity | 0.06 |
| Long-term debt / equity | 0.04 |
| Options and short | No / Yes |
Earnings
Ownership
| Insiders own | 61.35% |
|---|---|
| Insider trades | 0.00% |
| Institutions own | 0.87% |
| Institution trades | 1.15% |
| Return on assets | -357.22% |
| Return on equity | -411.08% |
| Return on capital | -210.65% |
| Gross Margin | - |
| Operating margin | - |
| Profit Margin | - |
| 20-day average | 5.96% |
| 50-day average | 14.21% |
| 200-day average | -7.41% |
Technical
| Shares out | 1.42M |
|---|---|
| Shares floating | 0.61M |
| Short / float | 0.97% |
| Short ratio | 0.27 |
| Short interest | 0.01M |
| 52-week high | 13.33 -57.5% |
| 52-week low | 3.58 +58.6% |
| Volatility | 2.77% 7.67% |
| Average range | 0.45 |
| Strength index | 55.29 |
| Market sensitivity | -3.04 |
| Relative volume | 0.06 |
| Avg Volume | 22.01K |
| Volume | 1,330 |
Performance
| Perf Week | -1.90% |
|---|---|
| Perf Month | 14.31% |
| Perf Quarter | 30.40% |
| Perf Half Y | -9.40% |
| Perf YTD | -14.25% |
| Perf Year | -50.77% |
| Perf 3Y | - |
| Perf 5Y | - |
| Perf 10Y | - |
| Recommendation | - |
| Target Price | - |
| Prev Close | 5.66 |
| Price | 5.67 |
| Change % | 0.18% |
Peers
Mkt capQuarterly earnings
actual against estimate| Period | Reported | EPS act | EPS est | EPS rep | Sales act | Sales est | Analysts |
|---|---|---|---|---|---|---|---|
| No quarterly earnings. | |||||||
Annual earnings
| Period | EPS act | EPS est | EPS rep | Sales act | Sales est |
|---|---|---|---|---|---|
| No annual earnings. | |||||
Estimate revisions
last 14 periods| Period | Type | Date | Estimates | Up | Down | Mean | Low | High |
|---|---|---|---|---|---|---|---|---|
| No estimate revisions. | ||||||||
Estimate history
| EPS, annual | -0.014 | -0.261 | -2.982 | -7.385 | |||||
|---|---|---|---|---|---|---|---|---|---|
| Period | 2023 | 2024 | 2025 | TTM | |||||
| EPS, quarterly | -0.032 | -0.072 | -0.099 | -0.099 | -0.043 | -0.673 | -2.169 | -2.223 | -2.32 |
| Period | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | Q2 '26 |
| Sales, annual | 0 | 0 | 0 | 0 | |||||
| Period | 2023 | 2024 | 2025 | TTM | |||||
| Sales, quarterly | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Period | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | Q2 '26 |
| Shares, annual | 1.388 | 1.388 | 1.417 | 1.418 | |||||
| Period | 2023 | 2024 | 2025 | MRQ | |||||
| Shares, quarterly | 1.388 | 1.388 | 1.388 | 1.388 | 1.388 | 1.417 | 1.417 | 1.418 | 1.418 |
| Period | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | Q2 '26 |
Income statement, annual
| Metric | TTM | 2025FY | 2024FY | 2023FY |
|---|---|---|---|---|
| Total Revenue | 0.00 | 0.00 | 0.00 | 0.00 |
| Cost of Goods Sold Incl. D&A | 0.12 | 0.08 | 0.00 | 0.00 |
| Gross Profit | -0.12 | -0.08 | 0.00 | -0.00 |
| Selling, General and Administrative Excl. Other | 10.43 | 4.16 | 0.29 | 0.02 |
| Research and Development | 7.83 | 2.99 | - | - |
| Other Operating Expense | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Income | -10.55 | -4.24 | -0.29 | -0.02 |
| Interest Expense | - | 0.01 | 0.00 | 0.00 |
| Unusual Expense | 0.00 | 0.00 | 0.07 | 0.00 |
| Net Income Before Taxes | -10.47 | -4.23 | -0.36 | -0.02 |
| Income Taxes | 0.00 | 0.00 | 0.00 | 0.00 |
| Consolidated Net Income | -10.47 | -4.23 | -0.36 | -0.02 |
| Net Income From Continuing Operations | -10.47 | -4.23 | -0.36 | -0.02 |
| Net Income | -10.47 | -4.23 | -0.36 | -0.02 |
| EPS (Recurring) | -7.38 | -2.98 | -0.22 | -0.01 |
| EPS (Basic, Before Extraordinaries) | -7.38 | -2.98 | -0.26 | -0.01 |
| EPS (Diluted) | -7.38 | -2.98 | -0.26 | -0.01 |
| EBITDA | -10.43 | -4.16 | -0.29 | -0.02 |
| Non-Operating Income (Expense) | 0.09 | 0.02 | 0.00 | 0.00 |
| Other After Tax Adjustments | 0.00 | 0.00 | 0.00 | 0.00 |
| Shares Outstanding | 1.42 | 1.42 | 1.39 | 1.39 |
| Market Capitalization | 8.89 | 8.89 | 9.49 | - |
Income statement, quarterly
| Metric | 2026Q2 | 2026Q1 | 2025Q4 | 2025Q3 | 2025Q2 | 2025Q1 | 2024Q4 | 2024Q3 |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cost of Goods Sold Incl. D&A | 0.04 | 0.04 | 0.03 | 0.02 | 0.02 | 0.01 | 0.00 | 0.00 |
| Gross Profit | -0.04 | -0.04 | -0.03 | -0.02 | -0.02 | -0.01 | 0.00 | 0.00 |
| Selling, General and Administrative Excl. Other | 3.29 | 3.15 | 3.06 | 0.94 | 0.04 | 0.12 | 0.06 | 0.10 |
| Research and Development | 2.59 | 2.26 | 2.31 | 0.68 | - | - | - | - |
| Other Operating Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Income | -3.33 | -3.18 | -3.09 | -0.95 | -0.06 | -0.14 | -0.06 | -0.10 |
| Interest Expense | 0.00 | 0.00 | - | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Unusual Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.07 | 0.00 |
| Net Income Before Taxes | -3.29 | -3.15 | -3.07 | -0.95 | -0.06 | -0.14 | -0.14 | -0.10 |
| Income Taxes | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Consolidated Net Income | -3.29 | -3.15 | -3.07 | -0.95 | -0.06 | -0.14 | -0.14 | -0.10 |
| Net Income From Continuing Operations | -3.29 | -3.15 | -3.07 | -0.95 | -0.06 | -0.14 | -0.14 | -0.10 |
| Net Income | -3.29 | -3.15 | -3.07 | -0.95 | -0.06 | -0.14 | -0.14 | -0.10 |
| EPS (Recurring) | -2.32 | -2.22 | -2.17 | -0.67 | -0.04 | -0.10 | -0.06 | -0.07 |
| EPS (Basic, Before Extraordinaries) | -2.32 | -2.22 | -2.17 | -0.67 | -0.04 | -0.10 | -0.10 | -0.07 |
| EPS (Diluted) | -2.32 | -2.22 | -2.17 | -0.67 | -0.04 | -0.10 | -0.10 | -0.07 |
| EBITDA | -3.29 | -3.15 | -3.06 | -0.94 | -0.04 | -0.12 | -0.06 | -0.10 |
| Non-Operating Income (Expense) | 0.03 | 0.03 | 0.02 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other After Tax Adjustments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Stock Option Compensation Expense | 0.00 | 0.01 | - | - | - | - | - | - |
| Shares Outstanding | 1.42 | 1.42 | 1.42 | 1.42 | 1.39 | 1.39 | 1.39 | 1.39 |
| Market Capitalization | 8.89 | 14.50 | 9.37 | 20.41 | 21.79 | - | - | - |
Balance sheet, annual
| Metric | 2025FY | 2024FY | 2023FY |
|---|---|---|---|
| Cash & Short Term Investments | 4.97 | 0.15 | 0.07 |
| Short Term Receivables | 0.00 | 0.00 | 0.00 |
| Inventories | 0.00 | 0.00 | 0.00 |
| Other Current Assets | 6.25 | 0.37 | 0.00 |
| Total Current Assets | 11.23 | 0.52 | 0.07 |
| Net Property, Plant & Equipment | 0.35 | 0.00 | 0.00 |
| Total Investments and Advances | 0.00 | 0.00 | 0.00 |
| Intangible Assets | 0.00 | 0.00 | 0.00 |
| Other Assets | 0.00 | 0.00 | 0.00 |
| Total Assets | 11.58 | 0.52 | 0.07 |
| Short Term Debt Incl. Current Port. of LT Debt | 0.12 | 0.00 | 0.00 |
| Accounts Payable | 0.00 | 0.00 | 0.00 |
| Income Tax Payable | 0.00 | 0.00 | 0.00 |
| Other Current Liabilities | 0.01 | 0.01 | 0.01 |
| Total Current Liabilities | 0.14 | 0.01 | 0.01 |
| Long Term Debt | 0.22 | 0.00 | 0.00 |
| Provision for Risks Charges | 0.00 | 0.00 | 0.00 |
| Other Liabilities | 0.00 | 0.00 | 0.00 |
| Total Liabilities | 0.36 | 0.01 | 0.01 |
| Non-Equity Reserves | 0.00 | 0.00 | 0.00 |
| Preferred Stock - Carrying Value | 0.00 | 0.00 | 0.00 |
| Common Equity | 11.22 | 0.50 | 0.06 |
| Total Shareholders Equity | 11.22 | 0.50 | 0.06 |
| Accumulated Minority Interest | 0.00 | 0.00 | 0.00 |
| Total Equity | 11.22 | 0.50 | 0.06 |
| Total Liabilities & Stockholders Equity | 11.58 | 0.52 | 0.07 |
| Book Value Per Share | 7.92 | 0.36 | 0.04 |
| Tangible Book Value Per Share | 7.92 | 0.36 | 0.04 |
| Full-Time Employees | 6 | - | - |
| Price to Book Ratio | 1.68 | 0.66 | - |
| Return on Assets | -69.85 | -122.07 | - |
| Return on Equity | -72.09 | -128.32 | - |
| Return on Invested Capital | -36.92 | -71.82 | -31.95 |
| Quick Ratio | 81.93 | 35.54 | 5.21 |
| Current Ratio | 81.93 | 35.54 | 5.21 |
Cash flow, annual
| Metric | TTM | 2025FY | 2024FY | 2023FY |
|---|---|---|---|---|
| Net Income | -10.47 | -4.23 | -0.36 | -0.02 |
| Depreciation | 0.12 | 0.08 | 0.00 | 0.00 |
| Other Funds (Non Cash) | 0.01 | 0.00 | 0.07 | 0.00 |
| Funds from Operations | -10.33 | -4.15 | -0.29 | -0.02 |
| Extraordinary Item | 0.00 | 0.00 | 0.00 | 0.00 |
| Changes in Working Capital | -1.75 | -6.34 | -0.27 | 0.02 |
| Cash from Operating Activities | -12.08 | -10.48 | -0.56 | -0.00 |
| Capital Expenditures | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Assets From Acquisitions | 0.00 | 0.00 | 0.00 | 0.00 |
| Sale of Fixed Assets and Businesses | 0.00 | 0.00 | 0.00 | 0.00 |
| Purchase or Sale of Investments | 0.00 | 0.00 | 0.00 | 0.00 |
| Purchase of Investments | 0.00 | 0.00 | 0.00 | 0.00 |
| Sale Or Maturity of Investments | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Uses | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Sources | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash from Investing Activities | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Dividends Paid | 0.00 | 0.00 | 0.00 | 0.00 |
| Change in Capital Stock | 15.31 | 15.31 | 0.63 | 0.00 |
| Repurchase of Common Pref Stock | 0.00 | 0.00 | 0.00 | 0.00 |
| Sale of Common Pref Stock | 15.31 | 15.31 | 0.63 | 0.00 |
| Proceedsfrom Stock Options | 15.31 | 15.31 | 0.63 | 0.00 |
| Issuance or Reduction of Debt, Net | -0.40 | 0.00 | 0.00 | 0.00 |
| Change in Long Term Debt | -0.40 | 0.00 | 0.00 | 0.00 |
| Issuance of Long Term Debt | -0.40 | 0.00 | 0.00 | 0.00 |
| Reduction of Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Financing Active Other Cash Flow | 0.00 | 0.00 | 0.00 | 0.07 |
| Other Financing Activities Uses | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash from Financing Activities | 14.91 | 15.31 | 0.63 | 0.07 |
| Net Change in Cash | 2.83 | 4.82 | 0.07 | 0.07 |
| Free Cash Flow | -12.08 | -10.48 | -0.56 | -0.00 |
| Preferred Dividends (Cash Flow) | - | - | - | 0.00 |
| Deferred Taxes & Investment Tax Credit | - | 0.00 | 0.00 | 0.00 |
Balance sheet, quarterly
| Metric | 2026Q2 | 2026Q1 | 2025Q4 | 2025Q3 | 2025Q2 | 2025Q1 |
|---|---|---|---|---|---|---|
| Cash & Short Term Investments | 2.94 | 4.02 | 4.97 | 5.83 | 0.11 | 0.20 |
| Short Term Receivables | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Inventories | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Current Assets | 1.85 | 4.08 | 6.25 | 8.59 | 0.60 | 0.50 |
| Total Current Assets | 4.79 | 8.09 | 11.23 | 14.42 | 0.71 | 0.70 |
| Net Property, Plant & Equipment | 0.28 | 0.32 | 0.35 | 0.06 | 0.08 | 0.09 |
| Total Investments and Advances | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Intangible Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Assets | 5.07 | 8.41 | 11.58 | 14.48 | 0.79 | 0.79 |
| Short Term Debt Incl. Current Port. of LT Debt | 0.09 | 0.11 | 0.12 | 0.06 | 0.07 | 0.06 |
| Accounts Payable | 0.00 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Tax Payable | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Current Liabilities | 0.01 | 0.01 | 0.01 | 0.12 | 0.01 | 0.13 |
| Total Current Liabilities | 0.10 | 0.13 | 0.14 | 0.19 | 0.08 | 0.19 |
| Long Term Debt | 0.18 | 0.20 | 0.22 | 0.00 | 0.41 | 0.23 |
| Provision for Risks Charges | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Liabilities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Liabilities | 0.29 | 0.33 | 0.36 | 0.19 | 0.48 | 0.42 |
| Non-Equity Reserves | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Preferred Stock - Carrying Value | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Common Equity | 4.79 | 8.08 | 11.22 | 14.29 | 0.31 | 0.37 |
| Total Shareholders Equity | 4.79 | 8.08 | 11.22 | 14.29 | 0.31 | 0.37 |
| Accumulated Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Equity | 4.79 | 8.08 | 11.22 | 14.29 | 0.31 | 0.37 |
| Total Liabilities & Stockholders Equity | 5.07 | 8.41 | 11.58 | 14.48 | 0.79 | 0.79 |
| Book Value Per Share | 3.38 | 5.70 | 7.92 | 10.09 | 0.22 | 0.26 |
| Tangible Book Value Per Share | 3.38 | 5.70 | 7.92 | 10.09 | 0.22 | 0.26 |
| Full-Time Employees | - | - | 6 | - | - | - |
| Price to Book Ratio | 1.68 | 1.80 | 0.84 | 1.43 | 71.38 | - |
| Return on Assets | -357.22 | -157.37 | -69.85 | -17.05 | -57.89 | - |
| Return on Equity | -411.08 | -171.42 | -72.09 | -17.27 | -85.25 | - |
| Return on Invested Capital | -66.22 | -38.03 | -26.86 | -6.68 | -8.48 | -23.15 |
| Quick Ratio | 45.95 | 62.87 | 81.93 | 77.53 | 9.37 | 3.61 |
| Current Ratio | 45.95 | 62.87 | 81.93 | 77.53 | 9.37 | 3.61 |
Cash flow, quarterly
| Metric | 2026Q2 | 2026Q1 | 2025Q4 | 2025Q3 | 2025Q2 | 2025Q1 |
|---|---|---|---|---|---|---|
| Net Income | -3.29 | -3.15 | -3.07 | -0.95 | -0.06 | -0.14 |
| Depreciation | 0.04 | 0.04 | 0.03 | 0.02 | 0.02 | 0.01 |
| Other Funds (Non Cash) | 0.00 | 0.01 | 0.00 | 0.00 | -0.00 | 0.00 |
| Funds from Operations | -3.25 | -3.11 | -3.04 | -0.93 | -0.05 | -0.12 |
| Extraordinary Item | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Changes in Working Capital | 2.17 | 2.15 | 2.18 | -8.25 | -0.24 | -0.03 |
| Cash from Operating Activities | -1.08 | -0.95 | -0.86 | -9.19 | -0.29 | -0.15 |
| Capital Expenditures | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Assets From Acquisitions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Sale of Fixed Assets and Businesses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Purchase or Sale of Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Purchase of Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Sale Or Maturity of Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Uses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Sources | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash from Investing Activities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Dividends Paid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Preferred Dividends (Cash Flow) | - | - | - | 0.00 | - | - |
| Change in Capital Stock | 0.00 | 0.00 | 0.00 | 15.31 | 0.00 | 0.00 |
| Repurchase of Common Pref Stock | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Sale of Common Pref Stock | 0.00 | 0.00 | 0.00 | 15.31 | 0.00 | 0.00 |
| Proceedsfrom Stock Options | 0.00 | 0.00 | 0.00 | 15.31 | 0.00 | 0.00 |
| Issuance or Reduction of Debt, Net | 0.00 | 0.00 | 0.00 | -0.40 | 0.20 | 0.20 |
| Change in Long Term Debt | 0.00 | 0.00 | 0.00 | -0.40 | 0.20 | 0.20 |
| Issuance of Long Term Debt | 0.00 | 0.00 | 0.00 | -0.40 | 0.20 | 0.20 |
| Reduction of Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Financing Active Other Cash Flow | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Financing Activities Uses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash from Financing Activities | 0.00 | 0.00 | 0.00 | 14.91 | 0.20 | 0.20 |
| Net Change in Cash | -1.08 | -0.95 | -0.86 | 5.72 | -0.09 | 0.05 |
| Free Cash Flow | -1.08 | -0.95 | -0.86 | -9.19 | -0.29 | -0.15 |
Revenue breakdown
| Revenue split | - |
|---|
Short interest
shares short against float, oldest to newest| Settlement | Of float | Shares short | Float | Avg volume |
|---|---|---|---|---|
| 2026-10-30 | 0.97% | 0.0M | 0.6M | 22.31K |
| 2026-10-15 | 0.85% | 0.0M | 0.6M | 20.54K |
| 2026-09-30 | 0.51% | 0.0M | 0.6M | 16.37K |
| 2026-09-15 | 0.46% | 0.0M | 0.6M | 14.31K |
| 2026-08-31 | 0.09% | 0.0M | 0.5M | 9.90K |
| 2026-08-14 | 0.25% | 0.0M | 0.5M | 4.44K |
| 2026-07-31 | 0.14% | 0.0M | 0.4M | 4.43K |
| 2026-07-15 | 0.14% | 0.0M | 0.4M | 4.56K |
| 2026-06-30 | 0.24% | 0.0M | 0.4M | 5.16K |
| 2026-06-15 | 0.39% | 0.0M | 0.4M | 7.30K |
| 2026-05-29 | 0.29% | 0.0M | 0.4M | 11.17K |
| 2026-05-15 | 0.43% | 0.0M | 0.4M | 211.92K |
| 2026-04-30 | 0.55% | 0.0M | 0.4M | 215.81K |
| 2026-04-15 | 0.58% | 0.0M | 0.4M | 220.98K |
| 2026-03-31 | 1.23% | 0.0M | 0.4M | 221.00K |
| 2026-03-13 | 4.81% | 0.0M | 0.4M | 219.84K |
| 2026-02-27 | 43.15% | 0.2M | 0.4M | 213.73K |
| 2026-02-13 | 0.52% | 0.0M | 0.4M | 10.86K |
| 2026-01-30 | 0.80% | 0.0M | 0.4M | 10.97K |
| 2026-01-15 | 0.70% | 0.0M | 0.4M | 16.53K |
Option chain
expiry 2026-11-12| Type | Strike | Bid | Ask | Last | IV | Open int | Volume | Delta | Theta | Vega |
|---|---|---|---|---|---|---|---|---|---|---|
| No option chain for this symbol. | ||||||||||
Latest SEC filings
30| Filed | Form | Description | Period | Link |
|---|---|---|---|---|
| 2026-10-19 | S-8 | Initial registration statement for securities to be offered to employees pursuant to employee benefit plans | SEC | |
| 2026-10-19 | 8-K | Current report | 2026-09-14 | SEC |
| 2026-09-04 | 8-K | Current report | 2026-09-03 | SEC |
| 2026-08-17 | 8-K | Current report | 2026-08-14 | SEC |
| 2026-08-14 | 10-Q | Quarterly report pursuant to Section 13 or 15(d) | 2026-06-30 | SEC |
| 2026-07-21 | S-8 | Initial registration statement for securities to be offered to employees pursuant to employee benefit plans | SEC | |
| 2026-06-29 | DEF 14C | Information Statement Pursuant to Section 14(c) of the Securities Exchange Act of 1934 | 2026-06-29 | SEC |
| 2026-06-18 | PRE 14C | Information Statement Pursuant to Section 14(c) of the Securities Exchange Act of 1934 | 2026-06-18 | SEC |
| 2026-05-14 | 8-K | Current report | 2026-05-14 | SEC |
| 2026-05-14 | 10-Q | Quarterly report pursuant to Section 13 or 15(d) | 2026-03-31 | SEC |
| 2026-05-07 | 8-K | Current report | 2026-05-05 | SEC |
| 2026-04-02 | 8-K | Current report | 2026-04-02 | SEC |
| 2026-03-30 | 10-K | Annual report pursuant to Section 13 or 15(d) | 2025-12-31 | SEC |
| 2026-03-06 | 8-K | Current report | 2026-03-01 | SEC |
| 2026-01-05 | 8-K | Current report | 2025-12-31 | SEC |
| 2025-11-17 | 10-Q | Quarterly report pursuant to Section 13 or 15(d) | 2025-09-30 | SEC |
| 2025-11-17 | NT 10-Q | 2025-09-30 | SEC | |
| 2025-11-06 | 8-K | Current report | 2025-11-05 | SEC |
| 2025-09-29 | 8-K | Current report | 2025-09-23 | SEC |
| 2025-09-12 | 8-K | Current report | 2025-09-12 | SEC |
| 2025-09-09 | 10-Q | Quarterly report pursuant to Section 13 or 15(d) | 2025-06-30 | SEC |
| 2025-09-02 | 3 | Initial statement of beneficial ownership of securities | 2025-08-25 | SEC |
| 2025-09-02 | 3 | Initial statement of beneficial ownership of securities | 2025-08-25 | SEC |
| 2025-09-02 | 3 | Initial statement of beneficial ownership of securities | 2025-08-25 | SEC |
| 2025-09-02 | 3 | Initial statement of beneficial ownership of securities | 2025-08-25 | SEC |
| 2025-09-02 | 3 | Initial statement of beneficial ownership of securities | 2025-08-25 | SEC |
| 2025-09-02 | 3 | Initial statement of beneficial ownership of securities | 2025-08-25 | SEC |
| 2025-09-02 | 3 | Initial statement of beneficial ownership of securities | 2025-08-25 | SEC |
| 2025-09-02 | 3 | Initial statement of beneficial ownership of securities | 2025-08-25 | SEC |
| 2025-09-02 | 3 | Initial statement of beneficial ownership of securities | 2025-08-25 | SEC |
Insider activity by month
| Month | Bought | Buys | Sold | Sells |
|---|---|---|---|---|
| 2026-11 | 0 | 0 | 0 | 0 |
| 2026-10 | 0 | 0 | 0 | 0 |
| 2026-09 | 0 | 0 | 0 | 0 |
| 2026-08 | 0 | 0 | 0 | 0 |
| 2026-07 | 0 | 0 | 0 | 0 |
| 2026-06 | 0 | 0 | 0 | 0 |
| 2026-05 | 0 | 0 | 0 | 0 |
| 2026-04 | 0 | 0 | 0 | 0 |
| 2026-03 | 0 | 0 | 0 | 0 |
| 2026-02 | 0 | 0 | 0 | 0 |
| 2026-01 | 0 | 0 | 0 | 0 |
| 2025-12 | 0 | 0 | 0 | 0 |
| 2025-11 | 0 | 0 | 0 | 0 |
Institutional holders
| Manager | % owned |
|---|---|
| CITADEL ADVISORS LLC | 0.34% |
| RENAISSANCE TECHNOLOGIES LLC | 0.18% |
| Virtu Financial LLC | 0.18% |
| GEODE CAPITAL MANAGEMENT, LLC | 0.13% |
| JANE STREET GROUP, LLC | 0.11% |
| TWO SIGMA INVESTMENTS, LP | 0.10% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 0.05% |
| Ground Swell Capital, LLC | 0.04% |
| CITIGROUP INC | 0.03% |
| Tower Research Capital LLC | 0.00% |
Funds
| Fund | % owned |
|---|---|
| Fidelity Extended Market Index Fund | 0.07% |
| Fidelity Nasdaq Composite Index Fund | 0.05% |
OakChart. CURX. Cached 15 minutes. Terms
Some panels did not load: ratings, insider, news.